Selank Dosing Protocol: Cycling, Frequency & Best Practices

Introduction

The registered Russian product Selanc has a specific approved dosing schedule. It is dispensed as a 0.15 percent intranasal solution and prescribed at 300 mcg three times daily, for a total of 900 mcg per day, in courses of 10 to 14 days. That’s the only protocol that has actually been studied in formal Russian clinical trials.

Outside of that registered protocol, selank gets dosed in a thousand different ways by people who buy it from the research peptide market. Some inject it subcutaneously, which has no published precedent in human studies. Some take much lower or much higher doses than the Russian protocol. Some run continuous daily dosing for months, which also has no clinical evidence base. This guide describes what has actually been studied and flags the unstudied variants for what they are.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Registered Russian Dosing Protocol?

The product label for Selanc, approved by the Russian Ministry of Health, specifies 300 mcg per dose, three doses per day, given by intranasal spray. That’s 900 mcg per 24 hours. Course length is 10 to 14 days for generalized anxiety disorder. The label recommends repeating courses no more often than every 2 to 4 months unless directed by a physician.

Quick Answer: Registered Russian protocol: 300 mcg intranasal three times daily, 10 to 14 day course

Each dose is administered as two to three sprays into the nasal mucosa, alternating nostrils. Patients are advised not to blow their nose for 5 to 10 minutes after dosing to allow absorption. The intranasal route delivers the peptide to both systemic circulation and the central nervous system through the olfactory and trigeminal nerve pathways.

This is the only protocol supported by Russian clinical trial data (Zozulia et al. 2008, Zh Nevrol Psikhiatr Im S S Korsakova).

What About Subcutaneous Dosing?

Some research peptide users inject selank subcutaneously. There’s no clinical trial data supporting this route in humans. Animal mechanism studies have used both intranasal and intraperitoneal injection, with comparable effects on neurotransmitter and gene expression endpoints. The pharmacokinetics differ: subcutaneous gives a sharper peak and shorter duration, intranasal gives more sustained exposure plus the possible direct CNS transport benefit.

If someone is going to inject selank, the doses used on forums typically range from 250 to 500 mcg per injection, given once or twice daily. The injection method is the same as for any peptide: small insulin syringe, subcutaneous in the abdomen or thigh, rotating sites. None of this has been validated in clinical trials. It’s experimentation with off label use of a non FDA approved drug.

How Long Should a Cycle Last?

The Russian protocol uses 10 to 14 day courses. This came out of the original clinical trials and matches the kinetics of the proposed mechanisms (BDNF upregulation, gene expression changes) that take days to weeks to develop. Cycles shorter than 7 days may not produce the full effect. Cycles longer than 21 days haven’t been studied in formal trials.

In practice, many users report that the anxiolytic effect builds over the first 3 to 5 days and is most pronounced in the second week. Discontinuation usually doesn’t produce rebound anxiety, in contrast to benzodiazepines. The Russian post marketing experience hasn’t reported significant withdrawal symptoms over two decades of clinical use.

How Often Should You Repeat Cycles?

The Russian label recommends 2 to 4 months between courses unless the prescriber directs otherwise. The rationale is partly that the anxiolytic effect persists for some time after discontinuation (likely because of the gene expression changes), and partly precautionary given limited data on continuous long term use.

In the gray market, repeat patterns vary widely. Some people run 2 week courses every 6 to 8 weeks. Some run continuous daily dosing for months. The continuous protocol has no clinical evidence base and the long term safety hasn’t been studied. Conservative practice would follow something close to the Russian recommendation: course of 10 to 14 days, off for at least 6 to 8 weeks, repeat as needed.

Should You Cycle Off Entirely?

There’s no clinical evidence requiring full discontinuation periods of any specific length. The Russian protocol’s 2 to 4 month gap between courses is more of a regulatory default than a pharmacokinetic necessity. Some clinicians use selank more flexibly based on individual patient response.

The reason cycling off makes sense is partly to avoid unknown long term effects on receptor expression or gene regulation, and partly to assess whether the anxiety symptoms have improved enough that continued dosing isn’t needed. Anxiety often has an episodic pattern, and selank’s gene expression effects may produce some lasting benefit that allows extended off periods.

How Should You Store Selank?

The registered Russian product is shelf stable at controlled room temperature with a typical pharmaceutical shelf life of 2 years. Research peptide selank is typically shipped lyophilized and requires reconstitution with bacteriostatic water before use. Reconstituted solution should be refrigerated and used within several weeks.

Bacteriostatic water has its own shelf life after opening, typically 28 days. Stability of the reconstituted peptide drops over weeks of storage. Most users prepare smaller batches more frequently rather than reconstituting a large vial all at once. For intranasal use, sterile saline can be used instead of bacteriostatic water, but stability is shorter.

Key Takeaway: Cycles typically repeated every 2 to 4 months rather than continuous use

What About Dose Titration?

The Russian protocol doesn’t titrate. Patients start at the full 300 mcg three times daily dose. The drug doesn’t produce significant acute sedation or other dose limiting side effects that would require gradual escalation. Some prescribers do start at a lower dose (150 mcg three times daily for the first 2 to 3 days) and increase to standard dosing, mostly as a comfort measure rather than a pharmacological necessity.

For people new to selank, starting at the lower end of the dosing range for the first few days makes sense from a tolerance and side effect monitoring perspective. If side effects (mild headache, nasal irritation) emerge, they can usually be managed by adjusting the dose or the administration technique.

Does Selank Interact with GLP-1 Dosing?

No published interaction data. Semaglutide is typically dosed once weekly subcutaneously, with titration from 0.25 mg to 2.4 mg over several months. Tirzepatide follows a similar pattern. The pharmacokinetic profiles are completely different from selank’s daily intranasal dosing, and the mechanisms don’t overlap.

For TrimRx patients on a personalized treatment plan with compounded semaglutide or tirzepatide, adding selank doesn’t change the GLP-1 dosing schedule. Selank cycles can be timed independently. The most important practical point is to tell your prescriber about the selank use so they have the full picture when interpreting your labs and managing your overall treatment.

What If You Miss a Dose?

For selank, missing a single intranasal dose isn’t a meaningful concern. The clinical effect depends on cumulative exposure over the course rather than precise peak concentrations. Take the next dose at the scheduled time. Don’t double up.

This is different from GLP-1 medications where missed doses can affect efficacy more directly. The TrimRx free assessment quiz and patient education materials cover GLP-1 missed dose management. Selank’s gentler kinetics mean less stringent adherence is required.

Are There Populations That Should Avoid Selank?

Pregnancy and lactation: no data, avoid by default. Selank crosses the blood brain barrier and its effects on fetal development haven’t been studied. Children: not studied, no pediatric dosing recommendations. Elderly patients with significant cognitive impairment: caution recommended, though there are some Russian reports of use in mild cognitive impairment with reasonable tolerability.

Patients on other serotonergic medications (SSRIs, SNRIs, MAOIs) should discuss with their prescriber. The serotonergic effects of selank are modest compared to direct serotonin reuptake inhibitors, but the theoretical interaction concern exists. There are no published cases of serotonin syndrome with selank but the data set is small.

Bottom line: No published protocol for combining selank with GLP-1 medications like semaglutide or tirzepatide

FAQ

Can I Take Selank Every Day for Months?

No clinical trial data supports this. The Russian protocol is 10 to 14 day cycles with breaks in between. Long term continuous use is unstudied.

How Long Until Selank Starts Working?

The first measurable anxiolytic effect typically appears within hours of the first dose, with full effect developing over 3 to 5 days of consistent dosing.

Should I Take Selank with Food?

It’s intranasal, so food intake doesn’t affect absorption. Subcutaneous injection (off label) is also not affected by meal timing.

What Time of Day Should I Dose?

The Russian protocol uses three doses spread across the day (morning, midday, evening). This maintains roughly steady state CNS exposure. Avoid dosing right before sleep if you find selank energizing.

Can I Stop Selank Suddenly?

Yes. There’s no clinically significant withdrawal syndrome documented in the Russian post marketing data, even after weeks of dosing. Stopping abruptly at the end of a cycle is standard practice.

How Does Dosing Compare to Semax?

Semax is dosed similarly (intranasal, multiple times per day) but at different concentrations and for different indications (cognition, stroke recovery). The two peptides are sometimes used in combination, with no published interaction data.

Is the 900 Mcg Per Day Dose Too Low for Some People?

That’s the Russian label maximum. Some research peptide users go higher. There’s no clinical evidence supporting higher dosing and no toxicity data above the label range. Stay at the studied dose unless you have a specific clinical reason and prescriber oversight.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.